Skip to main content
. 2022 Apr 23;10:39–61. doi: 10.1016/j.xjon.2022.04.028

Table 3.

Postoperative outcomes by CCT

Postoperative outcome All patients (n = 440), N (%) median [IQR] CCT <90 min (n = 100), N (%) median [IQR] CCT 90 < X < 180 min (n = 268), N (%) median [IQR] CCT ≥180 min (n = 72), N (%) median [IQR] P value
Inotropes on ICU admittance 335 (76) 67 (67) 204 (76) 64 (89) .004
VIS on ICU admission 4.94 [1.05-10.22] 3.3 [0-9.2] 4.5 [1.1-9.5] 7.6 [3-12.9] .001
Length of ICU stay, d 3 [1.6-6.1] 2.9 [1.4-5.6] 2.8 [1.5-5.9] 4.7 [2.3-9.6] .004
Length of hospital stay, d 8 [6-14] 9 [6-15] 8 [6-13] 10 [7-21] .020
Uneventful recovery 276 (63) 70 (70) 172 (64) 34 (47) .007
 In-hospital mortality 11 (3) 4 (4) 5 (2) 2 (3) .500
 Re-exploration for bleed 22 (5) 4 (4) 13 (5) 5 (7) .672
 Pacemaker implantation 30 (7) 2 (2) 19 (7) 9 (13) .025
 Respiratory failure 128 (29) 25 (25) 71 (27) 32 (44) .007
 Stroke 26 (6) 9 (9) 10 (4) 7 (10) .053
 Acute renal failure 27 (6) 4 (4) 19 (7) 5 (7) .672
 Deep sternal infection 4 (1) 2 (2) 1 (0) 1 (1) .307
 Postcardiotomy shock 15 (3) 2 (2) 7 (3) 6 (8) .040
Change in LVEF (%) 0 [−5 to 2.5] 0 [−4.88 to 2.5] 5 [−5 to 2.5] 0 [−2.5 to 2.6] .546
Decrease in RVSF 85 (21) 18 (20) 57 (24) 10 (15) .333

CCT, Crossclamp time; IQR, interquartile range; ICU, intensive care unit; VIS, vasoactive inotropic score; LVEF, left ventricular ejection fraction; RVSF, right ventricular systolic function.

P value < .05.